Series B investment underscores high growth opportunity for AI in life sciencesBOSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) — Labviva, the leading AI procurement platform for life sciences, today announced the close of its $25 million Series B, bringing its total funding to $55 million. Led by 53 Stations, with continued participation from Biospring Partners, B Capital Group, and Glasswing Ventures, the investment reflects the company’s boom growth and escalating demand in Biopharma for automated sup